General Range
OFLATUNE 200
Price on request/100 · MOQ 100 boxes
OFLATUNE 200 Tablets by Fortune Labs contain Ofloxacin 200 mg, a fluoroquinolone antibiotic used to treat selected bacterial infections caused by susceptible microorganisms. Ofloxacin works by inhibiting bacterial DNA replication, helping control bacterial growth and infection. OFLATUNE 200 may be prescribed for certain urinary tract, respiratory tract, gastrointestinal, and skin infections when clinically appropriate. Available in convenient 10 × 10 tablet blister packaging, this product is part of Fortune Labs' pharmaceutical portfolio. Fortune Labs offers PCD Pharma Franchise and distribution opportunities for authorized pharmaceutical businesses across India. Contact Fortune Labs for wholesale pricing, product availability, and franchise enquiries. Due to potentially serious adverse effects, Ofloxacin should be used only under medical supervision and according to prescribing guidelines.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Ofloxacin 200 mg
- Packaging Type
- Blister Pack
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- Bacterial urinary tract infections, certain respiratory tract infections, gastrointestinal infections, skin infections, and other infections caused by
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
